Skip to search formSkip to main contentSkip to account menu

DLL4 gene

Known as: Delta-Like 4 (Drosophila) Gene, DLL4, DELTA-LIKE 4 
This gene is involved in the notch signal transduction pathway.
National Institutes of Health

Related topics

Related topics

8 relations
Blood CirculationCell Differentiation processDLL1 geneDLL3 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Corrigendum: Novel missense mutation in DLL4 in a Japanese sporadic case of Adams–Oliver syndrome
This corrects the article DOI: 10.1038/jhg.2017.48 
2016
2016
[CHANGES OF THE CONTENT OF DLL4 AND Jag-1 ANGIOGENESIS REGULATORS IN HUMAN DERMIS IN ONTOGENESIS].
The goal of this study was to examine the contents of D114 and Jag-1 angiogenesis regulators in human dermis at different age… 
2016
2016
High level of Delta-like ligand 4 suppresses the metastasis of hepatocellular carcinoma
This study aims to explore the role of Delta-like ligand 4 (DLL4) in human hepatocellular carcinoma (HCC), we examined the… 
2012
2012
Cancer stem cells: getting to the root of cancer.
Hamlet called his Denmark an “unweeded garden” governed by a despicable leader who would perpetuate corruption into future… 
2012
2012
Bispecific binding molecules that bind to Dll4 and Ang2
Coupled with both VEGF and Ang2, preferably bispecific binding molecule in the form of the immunoglobulin single variable domain… 
2011
2011
Abstract 2834: Anti-DLL4 treatment inhibits melanoma tumor growth, recurrence, metastases, and reduces frequency of cancer stem cells in a clinically relevant tumor model in NOD/SCID mice
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Metastatic burden at the time of diagnosis is often the… 
2011
2011
Therapeutic DLL4 associated proteins
This document describes DLL4 associated proteins, comprise antibody, the antibody of CDR grafting, humanized antibody and DLL4… 
2009
2009
Dll4 directed to antibodies and uses thereof
The present invention relates to use of a targeted binding agent and such agents against DLL4. More particularly, the present… 
2008
2008
Inhibiteurs de la signalisation dll4 et utilisations associees
L'invention concerne des anticorps se liant a DLL4, en particulier des anticorps empechant la signalisation Notch et l… 
2006
2006
TITLE : Notch and VEGF Interactions in Breast Cancer PRINCIPAL INVESTIGATOR
s Zaghloul, N., Hernandez, S., Tsai, J., Bae, J., Huang, J., Lee, A., Zimmermann, R., Shawber, C.J., Kitajewski, J., Kandel, J.J…